Isolation, Identification, Anti-Inflammatory, and In Silico Analysis of New Lignans from the Resin of .

Pharmaceuticals (Basel)

The Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.

Published: September 2023

K. M. Shen (Apiaceae) is distributed in arid desert areas of Xinjiang, and its resin is a traditional Chinese medicine to treat gastrointestinal digestive diseases. To explore bioactive components from , three new lignans and thirteen known components were isolated. The structural elucidation of the components was established utilizing spectroscopic analyses together with ECD calculations. Griess reaction results indicated new compounds and significantly decreased NO production in LPS-stimulated RAW 264.7 macrophages, and ELISA results indicated that they effectively attenuated LPS-induced inflammation by inhibiting TNF-α, IL-1β, and IL-6 expressions. The in silico approach confirmed that compound docked into the receptors with strong binding energies of -5.84~-10.79 kcal/mol. In addition, compound inhibited the proliferation of AGS gastric cancer cells with IC values of 15.2 μM by suppressing the cell migration and invasion. This study disclosed that might be a promising potential resource for bioactive components.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610263PMC
http://dx.doi.org/10.3390/ph16101351DOI Listing

Publication Analysis

Top Keywords

bioactive components
8
isolation identification
4
identification anti-inflammatory
4
anti-inflammatory silico
4
silico analysis
4
analysis lignans
4
lignans resin
4
resin shen
4
shen apiaceae
4
apiaceae distributed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!